Navigation Links
Ametros Financial Names Thomas Ash as CEO
Date:12/12/2011

BURLINGTON, Mass., Dec. 12, 2011 /PRNewswire-iReach/ -- Thomas Ash was named chief executive officer of Ametros Financial. Tom joined Ametros as executive vice president in February 2011. Prior to that, he spent two decades in the workers' compensation managed care industry. He served as vice president and national sales executive with Progressive Medical, vice president of national occupational health for Kaiser Permanente, division president of workers' compensation for First Health Corporation, and president and CEO of four wholly owned subsidiaries of Health Net, Inc. Tom served on the Board of the National Association of Occupational Health Professionals and is the charter recipient of the California Jaycees Miracle Man Award.

(Photo:  http://photos.prnewswire.com/prnh/20111212/CG21163)

"Tom's proven skills coupled with his experience in leadership positions in the workers' compensation managed care industry make him the ideal fit to lead the company into its next stage of growth," said Tom Goundrey, managing director at Clarion Capital Partners, LLC.

"Tom's vision and strategy have established Ametros Financial as a significant player in the post-settlement administration space," said Sandra O'Sullivan, president at Ametros Financial.  "We are looking forward to the future with him at the helm."

Ametros Financial is a collaboration of Property & Casualty and Medicare Set-Aside (MSA) professionals with a vision to solve for the settlement challenges facing insurers, third-party administrators and employers today. Ametros offers an innovative product suite that anticipates the unique needs of all the key players to a settlement including claimants/plaintiffs, insurers, employers, attorneys, structured settlement brokers and medical providers. The company is principally owned by Clarion Capital Partners, LLC, a New York based private equity firm. 

Media Contact: Sarah Gernux, Ametros Financial Corporation, 978-405-2276, sgernux@ametrosfinancial.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Ametros Financial Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):